Treating Acute Leukemias
in Europe
A Worldwide Collaboration to Define and Refine the Most Effective Treatments in Leukemias
Overview
In recent years, progress in the understanding of acute leukemias has led to novel therapies that are rapidly changing treatment paradigms. Aptitude Health developed the Global Leukemia Academy to help physicians who treat acute leukemias bridge the gap between innovation and implementation for patient care.
Date and Location
23–24 September 2022, Virtual Meeting
Meeting Content
View the slides and watch the video of Day 1
Virtual Plenary Sessions
View the slides and watch the video of Day 2
Virtual Breakout: Adult ALL Patients
View the slides and watch the video of Day 2
Virtual Breakout: Pediatric ALL Patients
View the slides and watch the video of Day 2
Virtual Breakout: Adult AML Patients
Ask your questions directly to the experts and receive their personal insights on current and novel treatment approaches for pediatric and adult patients with acute leukemias.
Co-chairs
Elias Jabbour, MD
MD Anderson Cancer Center, USA
Franco Locatelli, MD, PhD
Sapienza, University of Rome
IRCCS Bambino Gesù Children’s Hospital,
Italy
Naval Daver, MD
MD Anderson Cancer Center, USA
Gail J. Roboz, MD
Weill Cornell Medicine and New York-Presbyterian Hospital, USA
Faculty
Josep-Maria Ribera, MD, PhD
Catalan Institute of Oncology, University Hospital Germans Trias i Pujol,
Spain
Agnieszka Wierzbowska, MD, PhD
Medical University of Lodz,
Poland
Rob Pieters, MD, PhD
Princess Máxima Center for Pediatric Oncology, University of Utrecht,
The Netherlands
Nicola Gökbuget, MD
University Hospital Frankfurt, Germany
Christina Peters, MD
St. Anna Children’s Hospital, Austria
Nicolas Boissel, MD, PhD
Hôpital Saint-Louis, France
|
Agenda |
This 2-day interactive virtual meeting with global experts will focus on the management of acute leukemia patients in Europe Day 1: Follow presentations, listen to expert opinions on hot topics in leukemias, engage with the faculty in panel discussions on optimal treatment and patient access, and regional challenges across Europe. Day 2: Join the pediatric, adult, or AML breakout session to learn about treatment strategies for newly diagnosed and relapsed/refractory leukemia patients and attend the patient case-based panel discussions focusing on toxicity management. |
Day 1 – PLENARY SESSIONS Friday, 23 September 2022
Chair: Elias Jabbour, MD
Co-chairs: Gail J. Roboz, MD, and Naval Daver, MD
14.30 – 18.00 CEST (UTC +2)
| Time (CEST) | Topic | Presenter |
| 14.30 – 14.40 | Welcome and Meeting Overview | Elias Jabbour |
| 14.40 – 15.05 | What’s New in ALL? Recent Developments in Research and Management | TBC |
| 15.05 – 15.25 | The Clinical Value of MRD in ALL: How MRD Can Guide the Use of Targeted Agents or Immunotherapy | Josep-Maria Ribera |
| 15.25 – 15.45 | How to Optimally Sequence CD19-Targeted Approaches in ALL | Elias Jabbour |
| 15.45 – 16.10 | Hot Topics and Regional Challenges of ALL Management • Interactive discussion and Q&A |
Moderator: Elias Jabbour All faculty |
| 16.10 – 16.20 | Break | |
| 16.20 – 16.45 | What’s New in AML? Recent Developments in Research and Management | Naval Daver |
| 16.45 – 17.05 | Genetic Characterization and Risk Stratification in AML | Agnieszka Wierzbowska |
| 17.05 – 17.25 | Moving the Treatment of AML to the Outpatient Setting: Is It Feasible? | Gail J. Roboz |
| 17.25 – 17.50 | Hot Topics and Regional Challenges of AML Management • Interactive discussion and Q&A |
Moderators: Gail J. Roboz and Naval Daver All faculty |
| 17.50 – 18.00 | Session Close | Elias Jabbour |
Day 2 – BREAKOUT: ADULT ALL PATIENTS Saturday, 24 September 2022
Chair: Elias Jabbour, MD
11.00 – 13.45 CEST (UTC +2)
| Time (CEST) | Topic | Presenter |
| 11.00 – 11.10 | Session Open | Elias Jabbour |
| 11.10 – 11.35 | Optimizing First-Line Therapy in Adult and Older ALL: Integration of Immunotherapy Into Frontline Regimens | Nicolas Boissel |
| 11.35 – 12.00 | Current Treatment Options for Relapsed ALL in Adult and Older Patients | Nicola Gökbuget |
| 12.00 – 12.40 | ALL Case-Based Panel Discussion • Local case 1: Frontline setting (10 min) • Local case 2: Relapsed/refractory setting (10 min) • Discussion and Q&A (20 min) |
Moderator: Elias Jabbour Local case presenters All faculty |
| 12.40 – 12.50 | Break | |
| 12.50 – 13.10 | Beyond the Horizon: New and Future Treatment Approaches for Adult and Older ALL | Nicola Gökbuget |
| 13.10 – 13.35 | Interactive Discussion: Treatment Landscape Evolution | Moderator: Elias Jabbour All faculty |
| 13.35 – 13.45 | Session Close | Elias Jabbour |
Day 2 – BREAKOUT: PEDIATRIC ALL PATIENTS Saturday, 24 September 2022
Chair: Franco Locatelli, MD, PhD
10.00 – 12.45 CEST (UTC +2)
| Time (CEST) | Topic | Presenter |
| 10.00 – 10.10 | Session Open | Franco Locatelli |
| 10.10 – 10.30 | How to Use MRD and Genetics for Stratification and Therapy Guidance in First-Line Therapy of Childhood ALL | Rob Pieters |
| 10.30 – 10.55 | Optimizing First-Line Therapy in Pediatric ALL: How to Balance Cure and Long-term Risks? | Rob Pieters |
| 10.55 – 11.35 | ALL Case-Based Panel Discussion • Local case 1: Frontline setting (10 min) • Local case 2: Management of long-term toxicities (10 min) • Discussion and Q&A (20 min) |
Moderator: Franco Locatelli Local case presenters All faculty |
| 11.35 – 11.45 | Break | |
| 11.45 – 12.15 | Current Treatment Options for Relapsed ALL in Children | Christina Peters |
| 12.15 – 12.35 | ALL Case-Based Panel Discussion • Local case 3: Relapsed/refractory setting (10 min) • Discussion and Q&A (10 min) |
Moderator: Franco Locatelli Local case presenter All faculty |
| 12.35 – 12.45 | Session Close | Franco Locatelli |
Day 2 – BREAKOUT: AML PATIENTS Saturday, 24 September 2022
Co-chairs: Gail J. Roboz, MD, and Naval Daver, MD
14.30 – 17.15 CEST (UTC +2)
| Time (CEST) | Topic | Presenter |
| 14.30 – 14.40 | Session Open | Gail J. Roboz and Naval Daver |
| 14.40 – 15.00 | Personalized Induction and Maintenance Approaches for AML | Gail J. Roboz |
| 15.00 – 15.25 | Fit and Unfit AML Patients: How Do We Distinguish? How Do We Treat Differently? | Agnieszka Wierzbowska |
| 15.25 – 16.05 | AML Case-Based Panel Discussion • Local case 1: Fit AML (10 min) • Local case 2: Unfit AML (10 min) • Discussion and Q&A (20 min) |
Moderators: Gail J. Roboz and Naval Daver Local case presenters All faculty |
| 16.05 – 16.15 | Break | |
| 16.15 – 16.40 | Optimizing Management of Relapsed/Refractory AML | Naval Daver |
| 16.40 – 17.05 | AML Case-Based Panel Discussion • Local case 3: Relapsed/refractory AML (10 min) • Discussion and Q&A (15 min) |
Moderators: Gail J. Roboz and Naval Daver Local case presenter All faculty |
| 17.05 – 17.15 | Session Close | Gail J. Roboz and Naval Daver |
